BLUE RABBIT VENTURES, INC.

Profile

Company Names

BLUE RABBIT VENTURES, INC.

Addresses

2 UNION STREET, SUITE 500, PORTLAND, ME 04101

Phone Numbers

(207) 329-9403

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$28,183,229.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-12-16 
$13,636,055.00 
$26,636,051.00 
$12,999,996.00 
Equity 
1
2021-03-24 
$14,547,174.00 
$14,547,174.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARISSA 
 
BERTORELLI 
DIRECTOR
BLUE RABBIT VENTURES, INC.
EDWARD 
L. 
CAHILL 
DIRECTOR
TANDEM DIABETES CARE INC   |  BINARY FOUNTAIN, INC.   |  CAREVIVE SYSTEMS, INC.   |  HLM VENTURE PARTNERS V, L.P.   |  BLUE RABBIT VENTURES, INC.   |  HLM STRATEGIC INVESTMENT FUND, L.P.   |  HLM CO-INVEST I, L.P.
JON 
 
LIM 
DIRECTOR
U S HEALTHVEST, LLC   |  PATIENTPING, INC.   |  ARTEMIS HEALTH INC.   |  PROTENUS, INC   |  EQUIP HEALTH, INC   |  BETTER LIFE PARTNERS INC.   |  EQUIP HEALTH, INC.   |  NOCD, INC.   |  WELL BEAM, INC.   |  BLUE RABBIT VENTURES, INC.   |  BETTER LIFE PARTNERS INC.   |  AUXILUS INC.
TERRANCE 
G. 
MCGUIRE 
DIRECTOR
IRONWOOD PHARMACEUTICALS INC   |  POLARIS VENTURE PARTNERS VI, L.P.   |  ACCELERON PHARMA INC   |  POLARIS PARTNERS VII, L.P.   |  MICROCHIPS BIOTECH, INC.   |  ADAGIO THERAPEUTICS, INC.   |  BLUE RABBIT VENTURES, INC.   |  JNANA THERAPEUTICS INC.
BENJAMIN 
J. 
SHAW 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
DIRECT VET MARKETING, INC.   |  BLUE RABBIT VENTURES, INC.
EMILY 
 
SNYDER 
DIRECTOR
BLUE RABBIT VENTURES, INC.
BRYCE 
 
YOUNGREN 
DIRECTOR
ALIMERA SCIENCES INC   |  EREWARDS INC   |  POLARIS VENTURE PARTNERS VI, L.P.   |  E-REWARDS INC   |  RESEARCH NOW GROUP INC   |  POLARIS ENTREPRENEURS- FUND VII, L.P.   |  CARDLYTICS, INC.   |  POLARIS GROWTH FUND I, L.P.   |  BLUE RABBIT VENTURES, INC.   |  POLARIS GROWTH FUND II, L.P.   |  POLARIS GROWTH FUND III, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-01-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-16 
2021-04-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#